Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states

Fig. 2

Representative slides from control group

Thrombus composition in a representative control case of acute ischemic stroke (control patient 3). H&E staining showing fibrin/platelet aggregates (pink) and red blood cells (red) seen on(A). Immunostaining for platelets (CD42b) (B, red), von Willebrand Factor (C, pink), thrombin-activatable fibrinolysis inhibitor, TAFI (D, pink), fibrinogen (E, pink) and plasminogen activator inhibitor, PAI-1 (F, pink)

Scale bar (A-F) = 2 mm.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us